B7家族成员B7-H6在肿瘤免疫中的研究进展
被引量:3
摘要
B7-H6是B7家族新成员,能够绑定受体NKp30启动NKp30依赖的固有免疫应答。B7-H6在正常组织细胞不表达而选择性的表达在一些肿瘤细胞和恶性血液病患者的血和骨髓,属于肿瘤诱导的自身分子。在感染和肿瘤状态下,应激能够调控B7-H6的表达。共刺激分子B7-H6作为连接固有免疫与适应性免疫应答的桥梁,在肿瘤免疫治疗方面的运用前景广泛,大量针对B7-H6的肿瘤靶向治疗方法在荷瘤小鼠身上取得了显著疗效”。本文就B7-H6在肿瘤免疫方面的研究进展展开综述。
出处
《中华微生物学和免疫学杂志》
CAS
CSCD
北大核心
2015年第12期932-934,共3页
Chinese Journal of Microbiology and Immunology
基金
江苏省高校优势学科建设工程资助项目
参考文献30
-
1Brandt CS, Baratin M, Yi EC, et al. The B7 family member BT- H6 is a tumor cell ligand for the activating natural killer cell recep- tor NKp30 in humans [ J ], J Exp Med, 2009, 206 (7) : 1495- 1503.
-
2Matta J, Baratin M, Chiche L, et al. Induction of B7-I-I6, a lig- and for the natural killer cell-activating receptor NKp30, in inflam- matory conditions[ J]. Blood, 2013, 122(3) : 394-404.
-
3Cao G, Wang J, Zheng X, et al. Tumor therapeutics work as stress inducers to enhance tumor sensitivity to NK cell cytolysis by upreg- ulating NKp30 ligand B7-H6 [ J]. J Biol Chem, 2015, 290(50) : 29964-29973.
-
4Wu MR, Zhang T, Gacerez AT, et al. BTH6-specific bispecific T cell engagers lead to tumor elimination and host antitumor immunity [J]. JImmunol, 2015, 194(11): 5305-5311.
-
5Zhang T, Wu MR, Sentman CL. An NKp30-based chimeric anti- gen receptor promotes T cell effector functions and antitumor effica- cy in vivo[J]. J lmmunol, 2012, 189(5) : 2290-2299.
-
6Pogge von Strandmann E, Simhadri VR, yon Tresckow B, et al. Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer ceils [J]. Immunity, 2007, 27(6): 965-974.
-
7Arnon TI, Achdout H, Levi O, et al. Inhibition of the NKp30 ac- tivating receptor by pp65 of human cytomegalovirus [ J ]. Nat Immunol, 2005, 6(5): 515-523.
-
8Mavoungou E, Held J, Mewono L, et al. A Duffy binding-like do- main is involved in the NKp30-mediated recognition of Plasmodiumfalciparum-parasitized erythrocytes by natural killer cells [ J]. J Infect Dis, 2007, 195 (10) : 1521-1531.
-
9Hecht ML, Rosental B, Horlacher T, et al. Natural cytotoxicity re- ceptors NKp30, NKp44 and NKp46 bind to different heparan sul- fate/hepafin sequences[J]. J Proteome Res, 2009, 8(2) : 712- 720.
-
10Li Y, Wang Q, Mariuzza RA. Structure of the human activating natural cytotoxicity receptor NKp30 bound to its tumor cell ligand B7-H6[J]. J Exp Med, 2011, 208(4) : 703-714.
同被引文献32
-
1Bran& CS, Baratin M, Yi EC, et al. The B7 l)amily member 117- H6 is a tumor cell ligand for Ihe aclivating natural killer eell recep- lor NKp30 in humans [ J ]. J Exp Ned, 2009, 206 (7) : 1495- 1503. DOl: 10. 1084/jem. 20090681.
-
2Malta J, Baratin M, Chiehe I,, el al. Induction of B7-H6, a lig- and fi~r lhe nalut~l killer eell-aclivating reeeplor NKp30, in inflaln- matory conditions[ J ]. Blood, 2013. 122 ( 3 ) : 394-404.
-
3Chen Y, He Y, Mo J. The B7 famiN nlember B7-H6 in tumor hnmunilv. Chin J Microbinl lmmunol, 2015, 35 ( 12 ) : 932-934 [ J 1. DOt : I O. 3760/cnm. j. issn. 0254-5101. 2015.12. 014.
-
4Li Y, ang Q, Mariuzza RA. Structure of tile hulnai'~ activating natural cytotoxicity receptor NKp30 bound to its tumor cell ligand B7-H6[J]. J Exp Med, 2011, 208(4): 703-714. DOt: 10. 1084/jem. 20102548.
-
5Kaitu T, Esealiere B, Gastinel LN, et al. B7-H6/NKp30 inlerac- lion: a mechanism of alerting NK cells against tmnors[J]. (2ell Mol Life Sci, 2011, 68 (21): 3531-3519. DOt: 10. 1007/ s00018-0r r -0802-7.
-
6Pesce S, Tabellini G, Cantoni C, el al. B7-H6-mediated down- regulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape[ J]. Oncoimmunnh~gy, 2015, 4 ( 4 ) : e1001224. eCollection 2015.
-
7Zhnu Y, Xu Y, Chen L, el al. B7-H6 expression correlates with ctlneer progression and patient's Stll3.'iva[ ill htlman ovarian cam'er [ J ]. lnl J Clin Exp Pathol, 2015, 8 (8) : 9428-9433. eColleclion 2015.
-
8Cao G, Wang J, Zheng X, el al. Tumor lherapeulies work us stress inducers to enhance lumor sensilivilv tn naturul killer (NK) cell cytulysis by up-regulating NKp30 Ligamt BT-H6 [ J ]. J Biol Chem, 2015, 290 (50) : 29964-29973.
-
9Schlecker E, Fiegler N, Arnold A, el aI. Metalloprotease-media- led tumor cell shedding of B7-H6, Ihe ligand ~f tile nalural killer cell-activating receplor NKp30 [ J]. ('ancer Res, 2014, 74( 13): 3429-3440.
-
10王珂,汪丽,程苏晶,冷维春.血清CA125和CA199检测对卵巢癌诊断应用价值的探讨[J].中国实验诊断学,2014,18(4):574-576. 被引量:31
引证文献3
-
1陈颖,何杨.鼠抗人B7-H6单克隆抗体的制备及其生物学特性鉴定[J].中华微生物学和免疫学杂志,2016,36(7):519-522.
-
2赵伟,郑凤俊,姚秀玲.HE4、CA125、B7-H4、B7-H6及Foxp3^+Treg联合检测在卵巢癌中的诊断价值[J].医学临床研究,2018,35(6):1044-1046. 被引量:5
-
3李艳玲,庄競,冯伟宇,王娜.血清TPS、B7H4水平与结直肠癌患者肿瘤发生发展的关系[J].实验与检验医学,2019,37(1):9-11. 被引量:3
二级引证文献8
-
1张智,张一琼.Foxp3+Tregs及PD1在上皮性卵巢癌组织中的表达及其临床病理意义[J].南昌大学学报(医学版),2018,58(5):54-58. 被引量:8
-
2杨成轩,贾良,孙艳霞,秦琛,原翔.共刺激因子B7同源体4在肺腺癌组织中的表达及临床意义[J].新乡医学院学报,2019,36(9):833-836. 被引量:4
-
3赵薇,徐鹏,田亚楠,匡野.白介素-33在妇科肿瘤中的研究进展[J].中华全科医学,2020,18(3):467-470. 被引量:3
-
4孔守芳,毛亚林,袁汇,孙选,钟金研,刘英.血清HSP40、sB7-H4在上皮性卵巢癌诊断及复发预测中的作用[J].中国妇产科临床杂志,2021,22(5):510-511. 被引量:3
-
5宋宝强,李贵轩,徐绍强,张作伟.血清LP、TTR、sB7-H1水平与初发结直肠癌患者TNM分期、淋巴结转移的关系及临床意义[J].热带医学杂志,2021,21(9):1197-1201. 被引量:3
-
6刘海兵,汪洪雷.超声Finkler评分联合血清CA125、CA724用于卵巢肿瘤良恶性鉴别诊断中的应用价值[J].医学信息,2022,35(20):56-59.
-
7柳灵,陈涛.血清CA125、SMRP、B7-H4联合检测用于卵巢癌诊断的敏感度与特异度分析[J].中外医学研究,2023,21(19):82-86. 被引量:2
-
8苑乐添,王艺霖,沈子剑,闫呈新.血清GDF15、sB7-H1联合多层螺旋CT灌注成像技术对胃癌患者淋巴结转移的诊断价值[J].中华消化病与影像杂志(电子版),2024,14(1):62-66.
-
1朱维维,童茵.B7家族成员在血液病的表达及意义[J].细胞与分子免疫学杂志,2013,29(11):1219-1221. 被引量:1
-
2鲁一,韩丽娟,慕竹青,周林静,孟娜娜,马晓艳,齐路霞,项红霞,何秋立,张桂芳.B7家族在非霍奇金淋巴瘤中的表达及意义[J].中华老年多器官疾病杂志,2015,14(11):834-837.
-
3郭莉婷(综述),姜藻(审校).肿瘤组织中B7-H4的表达及意义[J].国际肿瘤学杂志,2009,36(7):497-499.
-
4陈成,古涛,张学光,强亦忠.PD-L1信号在肿瘤免疫应答中的作用[J].中国肿瘤生物治疗杂志,2004,11(3):220-222. 被引量:1
-
5李俊芳,夏建国.共刺激分子B7与肿瘤免疫的研究进展[J].卫生职业教育,2008,26(13):148-151.
-
6卢斌峰,刘娟,吴昌平,蒋敬庭.微小RNA对T细胞的调控及机制[J].中华实验外科杂志,2013,30(2):416-418. 被引量:2
-
7沈红梅,季明春.B7-H1及其受体与肿瘤免疫逃逸[J].国外医学(肿瘤学分册),2005,32(2):116-118. 被引量:1
-
8李玉静,董万利.B7家族成员的研究新进展[J].国际免疫学杂志,2011,34(3):221-226. 被引量:6
-
9李文洲,张齐钧.共刺激分子B_7与肿瘤免疫[J].临床泌尿外科杂志,1997,12(6):369-372.
-
10张静.谈乳腺疾病近红外线扫描的应用前景[J].现代保健(医学创新研究),2007(10X):143-143.